Therapy reports

The Leading Partnering Intelligence Platform for Life Science Dealmakers

Custom Executive Partnering Briefings apply Current Partnering’s proprietary pharma and biotech deal intelligence to your company, pipeline or strategic priorities. Each briefing delivers focused analysis of relevant deals, potential partners, financial benchmarks and market trends. Standalone briefings start from USD$3,995 with a free proposed table of contents and scope available on request.

2,955 oncology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence

612 psychiatry partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence

1,762 infectious diseases partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence

Cardiovascular partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication analysis | Contract intelligence | Comprehensive deal directory

234 hematology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence

919 immunology partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence

319 genitourinary partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication and target analysis | Contract intelligence

438 gastrointestinal partnering deals | Financial benchmarks | Leading dealmakers and prospective partners | Therapeutic indication analysis | Contract intelligence